Contents of the Financial Statements

for the Period Ended 31 December 2017

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6

Company Information

for the Period Ended 31 December 2017

Director:		S Clift
		J Rothwell
		D Clough
		B Fisher
		V Patani
		M Josey
		L Campbell
Secretary:		J Armstrong
Registered office:		41 Vertical Pharma Resources Ltd Central Avenue West Molesey England KT8 2QZ
Company Registration Number:		05015111 (England and Wales)

Directors' Report Period Ended 31 December 2017

The directors present their report with the financial statements of the company for the period ended 31 December 2017

Directors

The directors shown below have held office during the whole of the period from 01 January 2017 to 31 December 2017
S Clift
J Rothwell
B Fisher

The director(s) shown below were appointed to the company during the period
V Patani
03 July 2017
L Campbell
01 November 2017

The director(s) shown below resigned during the period
D Clough
14 September 2017
M Josey
30 June 2017

Secretary
J Armstrong

Profit and Loss Account

for the Period Ended 31 December 2017

	2017 £	2016 £
Turnover	71,167	70,000
Cost of Materials	(1,085)	(1,244)
Other charges	(70,559)	(72,123)
Profit or (Loss) for Period	(477)	(3,367)

Balance sheet

As at 31 December 2017

	2017 £	2016 £
Current assets:	19,897	10,191
Creditors: amounts falling due within one year:	( 13,900 )	( 3,717 )
Net current assets (liabilities):	5,997	6,474
Total assets less current liabilities:	5,997	6,474
Total net assets (liabilities):	5,997	6,474
Capital and reserves:	5,997	6,474

Balance sheet continued

For the year ending 31 December 2017 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

The notes form part of these financial statements